Notice of Results

RNS Number : 3859E

Advanced Medical Solutions Grp PLC

09 February 2018

 

9 February 2018

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Notice of Preliminary Results

Winsford, UK, 9 February 2018: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, will announce its preliminary results for the year ended 31 December 2017 on Wednesday 14 March 2018.

A briefing for analysts will be held at 9.30am GMT on the day of results in the Guildhall Room at 85 Gresham Street, London EC2V 7NQ. Please contact Consilium Strategic Communications for further details.

-End -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc		Tel: [phone]
Chris Meredith, Chief Executive Officer Mary Tavener, Group Finance Director
Consilium Strategic Communications		Tel: [phone]
Mary-Jane Elliott / Matthew Neal / Philippa Gardner/ Rosie Phillips		[e-mail]
Investec Bank PLC (NOMAD & Broker)		Tel: [phone]
Daniel Adams / Gary Clarence / Patrick Robb

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Group has approximately 600 employees.  For more information, please see www.admedsol.com.

 

END

 

 

NORGMGGZRRMGRZM